BigHat Biosciences
San Francisco, US · Founded 2019 · Delaware corporation · 8 known investors
Big Hat Bio develops therapeutics under development across multiple programs. The company is a STEM-focused team working on therapeutic discovery and development.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
BigHat Biosciences was founded in 2019 by Peyton Greenside and Mark DePristo.
PG
Peyton GreensideCo-founder
MD
Mark DePristoCo-founder
Board
FG
SK
Steve KafkaBoard director
VA
RC
Robert ChessBoard director
Investors · 8
8VCAustin · $100K – $50M
Andreessen HorowitzMenlo Park · $500K – $50Mvia Vineeta Agarwala · board
BOLD LongevityBoston
Flucas VenturesJupiter · $100K – $5Mvia Ashley Flucas · inferred
GRIDS CapitalSão Paulo
AME Cloud VenturesreportedPalo Alto · $1M – $10M
Axial VCreportedSan Francisco · $100K – $5M
Section 32reportedPalo Alto
Reported raises · per SEC filings
Form D private placements$148.2M disclosed across 3 of 4 rounds · 2019–2024
▶$124.1MraisedApr 2025 · 40 investors · BiotechnologyRule 506(b)
▶$124.1MraisedApr 2025 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Francisco GimenezDirector
- Peyton GreensideExecutive Officer, Director
- Steve KafkaDirector
- Vineeta AgarwalaDirector
- Robert ChessDirector
- Offering amount
- $124.1M
- Amount sold
- $124.1M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18.8MraisedFeb 2021 · 6 investors · BiotechnologyRule 506(b)
▶$18.8MraisedFeb 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peyton GreensideExecutive Officer, Director
- Vineeta AgarwalaDirector
- Francisco GimenezDirector
- Mark DePristoExecutive Officer, Director
- Offering amount
- $19M
- Amount sold
- $18.8M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$5.3MraisedDec 2019 · 12 investors · BiotechnologyRule 506(b)
▶$5.3MraisedDec 2019 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Theresa TribblePromoter
- Francisco GimenezDirector
- Mark DePristoExecutive Officer, Director
- Peyton GreensideExecutive Officer, Director
- Offering amount
- $5.3M
- Amount sold
- $5.3M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through BigHat Biosciences went on to found or lead other companies.
Competitors · 1
by search overlapCompanies competing with BigHat Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does BigHat Biosciences do?
- Big Hat Bio develops therapeutics under development across multiple programs. The company is a STEM-focused team working on therapeutic discovery and development.
- Who founded BigHat Biosciences?
- BigHat Biosciences was founded by Peyton Greenside, Mark DePristo in 2019.
- Who are BigHat Biosciences's investors?
- BigHat Biosciences's investors include 8VC, Andreessen Horowitz, BOLD Longevity, Flucas Ventures, GRIDS Capital, AME Cloud Ventures, Axial VC, Section 32.
- How much funding has BigHat Biosciences raised?
- BigHat Biosciences has disclosed $148.2M raised across 3 of its 4 known rounds.
- Where is BigHat Biosciences headquartered?
- BigHat Biosciences is headquartered in San Francisco, US.